PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.10%
Negative revenue growth while ADI stands at 15.41%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.45%
Negative gross profit growth while ADI is at 16.49%. Joel Greenblatt would examine cost competitiveness or demand decline.
8.36%
EBIT growth below 50% of ADI's 32.85%. Michael Burry would suspect deeper competitive or cost structure issues.
-5.45%
Negative operating income growth while ADI is at 32.85%. Joel Greenblatt would press for urgent turnaround measures.
8.16%
Net income growth under 50% of ADI's 28.52%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.00%
EPS growth under 50% of ADI's 28.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.08%
Diluted EPS growth under 50% of ADI's 28.38%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.51%
Share reduction while ADI is at 0.54%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x ADI's 0.81%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
31.30%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-1.84%
Negative OCF growth while ADI is at 91.72%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.24%
FCF growth under 50% of ADI's 105.92%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
45.31%
10Y revenue/share CAGR at 50-75% of ADI's 70.85%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
13.86%
5Y revenue/share CAGR under 50% of ADI's 35.15%. Michael Burry would suspect a significant competitive gap or product weakness.
22.94%
3Y revenue/share CAGR under 50% of ADI's 49.68%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
141.93%
10Y OCF/share CAGR at 50-75% of ADI's 220.36%. Martin Whitman might fear a structural deficiency in operational efficiency.
62.92%
5Y OCF/share CAGR at 50-75% of ADI's 104.05%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
26.13%
3Y OCF/share CAGR under 50% of ADI's 74.54%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
131.02%
Similar net income/share CAGR to ADI's 134.68%. Walter Schloss would see parallel tailwinds or expansions for both firms.
300.73%
5Y net income/share CAGR above 1.5x ADI's 55.62%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
123.41%
3Y net income/share CAGR above 1.5x ADI's 48.60%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
35.88%
10Y equity/share CAGR at 50-75% of ADI's 64.91%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
9.07%
Below 50% of ADI's 31.25%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.67%
3Y equity/share CAGR at 50-75% of ADI's 10.22%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
1168.08%
10Y dividend/share CAGR above 1.5x ADI's 155.56%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
194.90%
5Y dividend/share CAGR above 1.5x ADI's 67.09%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.90%
3Y dividend/share CAGR above 1.5x ADI's 23.76%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-12.44%
Firm’s AR is declining while ADI shows 5.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.33%
Asset growth well under 50% of ADI's 3.71%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.34%
75-90% of ADI's 3.10%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-0.06%
We’re deleveraging while ADI stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-2.83%
Our R&D shrinks while ADI invests at 5.94%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.01%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.